The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price decrease of -93.36%. However, over the past six months, we’ve seen a stronger performance of -93.22%. The price of SLXN leaped by -48.94% over the last 30 days. And in the last five days, it has fallen by -24.88%.
Silexion Therapeutics Corp saw a rather unpredictable run in, in terms of market performance.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of SLXN Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Silexion Therapeutics Corp’s current trading price is -94.69% away from its 52-week high, while its distance from the 52-week low is -5.64%. The stock’s price range during this period has varied between$0.76 and $13.56. The Silexion Therapeutics Corp’s shares, which operate in the Healthcare, saw a trading volume of around 17.59 million for the day, a figure considerably higher than their average daily volume of 1.22 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Silexion Therapeutics Corp (SLXN) has experienced a quarterly decline of -93.58% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.79M.
Combining Moving Average and Trading Volume Data for Better Market Insight
SLXN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SLXN stands at 1.32. Similarly, the long-term debt-to-equity ratio is also 0.00.
